Mioriodol en es it fr

Mioriodol Brand names, Mioriodol Analogs

Mioriodol Brand Names Mixture

  • No information avaliable

Mioriodol Chemical_Formula


Mioriodol RX_link


Mioriodol fda sheet

Mioriodol msds (material safety sheet)

Mioriodol Synthesis Reference

Berger, Ludwig, U.S. Pat. 2,937,119 (1960)

Mioriodol Molecular Weight

260.33 g/mol

Mioriodol Melting Point

92-93 oC

Mioriodol H2O Solubility

0.3 mg/ml

Mioriodol State


Mioriodol LogP


Mioriodol Dosage Forms


Mioriodol Indication

For the relief of discomfort associated with acute, painful, musculoskeletal conditions.

Mioriodol Pharmacology

Carisoprodol is used as a skeletal muscle relaxant. One of its metabolites, meprobamate, is available as an anxiolytic agent.

Mioriodol Absorption

No information avaliable

Mioriodol side effects and Toxicity

Symptoms of overdose include drowsiness, giddiness, nausea, indigestion, or rash. Other adverse effects attributed to therapeutic use of carisoprodol include dizziness, irritability, insomnia, diplopia, temporary loss of vision, ataxia, weakness, headache, and dysarthria. Non-CNS adverse effects include gastrointestinal complaints, tachycardia, and postural hypotension. Patients sensitive to sulfites or tartrazine may experience wheezing, allergic rashes including erythema multiforme, or anaphylaxis after using some preparations of carisoprodol which contain such additives

Mioriodol Patient Information

Carisoprodol is a muscle relaxant used to relieve the pain and stiffness of muscle spasms and discomfort due to strain and sprain. Inform your physician if you are pregnant or nursing. Do not take this medication with a monoamine oxidase inhibitor. This medication may cause dizziness, drowsiness, or blurred vision; use caution while driving or operating hazardous machinery. Do not take any other sedating drugs or drink alcohol while taking carisoprodol. If dizziness occurs, avoid sudden changes in posture. Take this medication with food to avoid stomach upset. Notify your physician if you develop trouble breathing, unexplained fever, severe weakness, vision changes, swelling, or skin rash. Withdrawal symptoms may occur if therapy is suddenly stopped in a patient on long-term or high-dose therapy.

Mioriodol Organisms Affected

Humans and other mammals